A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ 61393215 in Healthy Participants
Clinical trial NCT03007693 · COMPLETED
Trial details
- NCT number
- NCT03007693
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2017-10-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.